Validation of an Allergic Rhinitis Control Test in Children

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Mar 6, 2017

Keywords

ClinConnect Summary

This clinical trial is studying a new way to assess how well allergic rhinitis (a condition that causes sneezing, runny nose, and other allergy symptoms) is controlled in children aged 5 to 11 years old. The researchers want to adapt an existing test, originally designed for adults and teens, to help younger kids. The goal is to better understand how effective current treatments are for allergic rhinitis and to improve the quality of life for children suffering from this condition.

To participate in this study, children must be between 5 and 11 years old and visiting a doctor for their allergic rhinitis. Parents will need to give their permission by signing a consent form. It's important to note that children who are currently satisfied with their allergy treatment will not be eligible for this study. Participants can expect to fill out a simple questionnaire about their symptoms, which will help researchers gather valuable information to improve care for children with allergic rhinitis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 5 to 11 years old, consulting a practitioner for an allergic rhinitis
• • Parents formulated their study participation agreement by signing the consent form.
• Exclusion Criteria:
• • Patients that are already treated for the actual episode of allergic rhinitis and are satisfied of the treatment.